GLS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Glenmark Life Sciences Ltd

Watchlist Manager

Watchlist

Price: 1 104.35 INR -2.31% Market Closed

Market Cap: ₹135.3B

G	Glenmark Life Sciences Ltd BSE:543322	IN
	Marr SpA MIL:MARR	IT

Profitability Summary

Glenmark Life Sciences Ltd's profitability score is 62/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

55%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

54% > 55%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

28%

Declining Operating Margin

30% > 25%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

22% > 19%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

6% > 12%

Positive ROE

17%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

Declining ROIC

27% > 20%

View All

Hide

Collapse

62 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.